CENTANY Drug Patent Profile
✉ Email this page to a colleague
When do Centany patents expire, and when can generic versions of Centany launch?
Centany is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in CENTANY is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Centany
A generic version of CENTANY was approved as mupirocin by PADAGIS ISRAEL on November 7th, 2003.
Summary for CENTANY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 2 |
Patent Applications: | 4,627 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in CENTANY? | CENTANY excipients list |
DailyMed Link: | CENTANY at DailyMed |
Recent Clinical Trials for CENTANY
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of North Carolina, Chapel Hill | Phase 2 |
University of Michigan | Phase 2 |
Indiana University | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for CENTANY
US Patents and Regulatory Information for CENTANY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | BX | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CENTANY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Padagis Us | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CENTANY
See the table below for patents covering CENTANY around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 69900561 | ⤷ Try a Trial | |
European Patent Office | 0933081 | Compositions pharmaceutiques contenant mupirocine (Pharmaceutical compositions containing mupirocin) | ⤷ Try a Trial |
Israel | 123143 | PHARMACEUTICAL COMPOSITIONS CONTAINING MUPIROCIN | ⤷ Try a Trial |
Spain | 2165723 | ⤷ Try a Trial | |
Canada | 2259764 | COMPOSITIONS PHARMACEUTIQUES RENFERMANT DE LA MUPIROCINE (PHARMACEUTICAL COMPOSITIONS CONTAINING MUPIROCIN) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |